# Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation

> **NCT00487656** · PHASE2 · COMPLETED · sponsor: **Artisan Pharma, Inc.** · enrollment: 750 (actual)

## Conditions studied

- Sepsis
- Disseminated Intravascular Coagulation

## Interventions

- **DRUG:** ART-123
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00487656
- **Lead sponsor:** Artisan Pharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2010-05
- **Final completion:** 2010-08
- **Target enrollment:** 750 (ACTUAL)
- **Last updated:** 2011-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00487656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00487656, "Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00487656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*